Menu

#Oncology

7 posts

Feed·
7 of 7 posts
Biotech Tops The 'Most Bullish Conversations' And Breaks Out
🖼️
0Read More

Biotech Tops The 'Most Bullish Conversations' And Breaks Out

Business - Latest - Google News·1 day ago
#FBLTN0dE
#world#news#investors#oncology#strength

CG Oncology said Monday its experimental bladder cancer treatment cut the risk of recurrence by 68%.

15s
Why Is CG Oncology Stock Soaring Today? - CG Oncology (NASDAQ:CGON)
🖼️
0Read More

Why Is CG Oncology Stock Soaring Today? - CG Oncology (NASDAQ:CGON)

Top Stories Feed·Vandana Singh·1 day ago
#R90LEsRc
#benzinga#oncology#stock#risk#high

CG Oncology reports Phase 3 data showing cretostimogene cuts bladder cancer recurrence risk by 68%, advancing two 2027 BLA filings.

15s
0Read More

ctDNA clearance and outcomes for resectable lung cancer from NeoCOAST-2

Nature·Cascone, Tina·24 days ago
#YVbc4F0K
#lm#oncology#orcid#university#access

Patients with resectable non-small cell lung cancer (NSCLC) remain at high risk of relapse despite perioperative treatment1-3. NeoCOAST-2 (NCT05061550), a phase 2, randomised platform trial, tested novel perioperative treatments in patients with stage…

15s